Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription 10.08.2026 7 AIDS 2 Antimicrob Agents Chemother 2 Clin Infect Dis 5 HIV Med 1 Int J Cancer 3 J Acquir Immune Defic Syndr 1 J Clin Invest 1 J Immunol 2 J Med Virol 1 JAMA 3 Lancet 1 Lancet Infect Dis 2 PLoS One 2 PLoS Pathog 1 Proc Natl Acad Sci U S A 1 Science 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. OSTRER L, Hastie E, Bamford L, Karim A, et al
   Ninety-six-week observational outcomes of long-acting injectable HIV therapy in people with adherence challenges, including people who use drugs.
   AIDS. 2026 Aug 6. doi: 10.1097/QAD.0000000000004599.
   PubMed         Abstract available
   
   
2. JENNESS SM, Manuelpillai B, Goodreau SM, Marcus JL, et al
   Evolving drivers of preexposure prophylaxis discontinuation among US MSM, 2018-2024.
   AIDS. 2026 Aug 6. doi: 10.1097/QAD.0000000000004593.
   PubMed         Abstract available
   
   
3. STADTLER H, Rubin LH, Neigh GN
   Distinct associations of peripheral mtDNA copy number and bioenergetic function with cognition in women with HIV and psychiatric comorbidities.
   AIDS. 2026 Aug 6. doi: 10.1097/QAD.0000000000004597.
   PubMed         Abstract available
   
   
4. MUCCINI C, Capra N, Lolatto R, Spagnuolo V, et al
   Two-year efficacy and safety of long-acting cabotegravir and rilpivirine in the SCohoLART study.
   AIDS. 2026 Aug 6. doi: 10.1097/QAD.0000000000004591.
   PubMed         Abstract available
   
   
5. TIWARI S, Chhapola V, Garg S, Jindal S, et al
   Longitudinal patterns of kidney function in children with HIV: insights from group-based trajectory modeling.
   AIDS. 2026 Aug 6. doi: 10.1097/QAD.0000000000004592.
   PubMed         Abstract available
   
   
6. HAIDAR L, Ruderman SA, Leong C, Doupe MB, et al
   Safety of semaglutide on depressive symptoms among people with HIV in routine clinical care.
   AIDS. 2026 Aug 6. doi: 10.1097/QAD.0000000000004598.
   PubMed         Abstract available
   
   
7. RUDERMAN SA, Crane HM, Haidar L, Drumright LN, et al
   Initiating semaglutide therapy reduces tobacco cigarette smoking intensity among people with HIV.
   AIDS. 2026 Aug 6. doi: 10.1097/QAD.0000000000004596.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

8. ROSSOUW J, Wallis R, Kornfeld H, Singhal A, et al
   The effect of metformin on the pharmacokinetics of rifampicin, isoniazid, and pyrazinamide in adults with tuberculosis.
   Antimicrob Agents Chemother. 2026 Aug 6:e0074826. doi: 10.1128/aac.00748.
   PubMed         Abstract available
   
   
9. WANG P, Meng Z, Zhou J, Wu H, et al
   Sorafenib enforces HIV-1 latency by selectively inhibiting PKC-driven STAT1/3 serine 727 phosphorylation.
   Antimicrob Agents Chemother. 2026 Aug 3:e0054026. doi: 10.1128/aac.00540.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

10. RONG R, Stoecker C, Kissinger PJ, Muzny CA, et al
    Cost-Effectiveness of Testing and Screening Strategies for Trichomoniasis among Asymptomatic and Symptomatic Women in U.S. Outpatient Clinical Settings.
    Clin Infect Dis. 2026 Aug 8:ciag465. doi: 10.1093.
    PubMed         Abstract available
    
    
11. SCOTT R, Olsen CH, Mancuso JD, Kibuuka H, et al
    Multimorbidity Trajectories and Hospitalization Risk Among People With Human Immunodeficiency Virus in Sub-Saharan Africa: A Longitudinal Analysis From the African Cohort Study.
    Clin Infect Dis. 2026 Aug 4:ciag353. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

12. NODZYNSKI K, Lessard D, Chu D, Kronfli N, et al
    Migration pathways and HIV care Cascade among newly enrolled adult patients in a tertiary clinic in Montreal, Canada.
    HIV Med. 2026 Aug 7. doi: 10.1111/hiv.70296.
    PubMed         Abstract available
    
    
13. NAKAMURA H, Falutz J, Naka T, Miyamori S, et al
    Frailty and associated clinical factors among Japanese people with HIV: A multicentre cross-sectional study using the revised Japanese Cardiovascular Health Study criteria.
    HIV Med. 2026 Aug 7. doi: 10.1111/hiv.70297.
    PubMed         Abstract available
    
    
14. LEONIDOU L, Lourida G, Protopapas K, Moschopoulos CD, et al
    Characteristics and management of low-level viraemia in people living with HIV in a resource-limited setting: A multicentre retrospective study in Greece.
    HIV Med. 2026 Aug 6. doi: 10.1111/hiv.70295.
    PubMed         Abstract available
    
    
15. METCALFE B, Maxwell KJ, Trayner K, Wilkinson M, et al
    A scoping review of the acceptability, feasibility and effectiveness of opt-out blood-borne virus (BBV) testing in secondary healthcare settings, in the UK and similar settings, using APEASE criteria.
    HIV Med. 2026 Aug 5. doi: 10.1111/hiv.70284.
    PubMed         Abstract available
    
    
16. PANTAZIS N, Vasalou V, Tsachouridou O, Papastamopoulos V, et al
    Migration-related inequalities in HIV diagnosis, treatment initiation and retention in care among migrants in Greece.
    HIV Med. 2026 Aug 2. doi: 10.1111/hiv.70294.
    PubMed         Abstract available
    
    

    
    Int J Cancer

17. POZZA G, Matone M, Oreni L, Carrozzo G, et al
    Non-AIDS-Defining Cancer Incidence in People With HIV in Milan, Italy, 2000-2023: Temporal Trends and Comparison With the General Population.
    Int J Cancer. 2026 Aug 7. doi: 10.1002/ijc.70689.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

18. TSUYUKI K, El-Krab R, Shoptaw S, El-Bassel N, et al
    "Delivering high-quality care in this setting requires a lot of resources": HPTN 094 Implementation Lessons from Delivering Integrated HIV and MOUD Care Through Mobile Units In Local Neighborhoods.
    J Acquir Immune Defic Syndr. 2026 Aug 5. doi: 10.1097/QAI.0000000000003947.
    PubMed         Abstract available
    
    
19. NYAKATO P, Euvrard J, Chinogurei C, Boulle A, et al
    HIV care interruptions during the first year of antiretroviral therapy among adolescents and young adults living with HIV aged 15-24 years in Khayelitsha, South Africa.
    J Acquir Immune Defic Syndr. 2026 Aug 6. doi: 10.1097/QAI.0000000000003948.
    PubMed         Abstract available
    
    
20. JAKABEK D, Bch Sci AC, Lancaster K, Brew BJ, et al
    Sources of Active Brain White Matter Injury in Virally Suppressed HIV Infection Revealed Through Fixel-Based Analysis.
    J Acquir Immune Defic Syndr. 2026 Aug 6. doi: 10.1097/QAI.0000000000003946.
    PubMed         Abstract available
    
    

    
    J Clin Invest

21. JALALI S, Natesampillai S, Nie Z, Zhang Y, et al
    TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo.
    J Clin Invest. 2026;136:e194449.
    PubMed         Abstract available
    
    

    
    J Immunol

22. PEREZ M, Zhu F, Carlin E, Greer BD, et al
    CD151 identifies a cytotoxic CD4 T cell population enriched in people with HIV that later develop cancer.
    J Immunol. 2026;215:vkag208.
    PubMed         Abstract available
    
    

    
    J Med Virol

23. ACHARYA A, Thurman M, Sutar D, Olasunkanmi OI, et al
    In-Vitro Evaluation of HIV/SARS-CoV-2 Co-Infection Mediated Proteomic Changes in Astrocytes and Pericytes Reveals Altered Signaling Pathways Associated With Neurodegenerative Disorders.
    J Med Virol. 2026;98:e71086.
    PubMed         Abstract available
    
    
24. KAN JY, Su HC, Lai HC, Lin YF, et al
    Darunavir and Fosamprenavir Inhibit Zika Virus Replication via Dual Targeting of the Envelope Protein and NS2B-NS3 Protease.
    J Med Virol. 2026;98:e71092.
    PubMed         Abstract available
    
    

    
    JAMA

25. ANDERER S
    First Once-Weekly Oral HIV Treatment Demonstrates Safety and Efficacy.
    JAMA. 2026 Aug 7. doi: 10.1001/jama.2026.12043.
    PubMed        
    
    

    
    Lancet

26. SINGER M, Machado FR, Kalil AC
    Towards a globally relevant sepsis agenda: the role of HIV - Authors' reply.
    Lancet. 2026;408:516-517.
    PubMed        
    
    
27. CUMMINGS MJ, Jacob ST, Bakamutumaho B
    Towards a globally relevant sepsis agenda: the role of HIV.
    Lancet. 2026;408:516.
    PubMed        
    
    
28. BISWAS S, Srivastava Y, Adepoju VA, Chintagumpala V, et al
    Power, dose, and fosfomycin in the SCOUT trial.
    Lancet. 2026;408:517.
    PubMed        
    
    

    
    Lancet Infect Dis

29. MAIR T
    Secret histories of the HIV epidemic.
    Lancet Infect Dis. 2026 Aug 7:S1473-3099(26)00438.
    PubMed        
    
    

    
    PLoS One

30. ZHANG J, Ding X, Fan Q, Yang J, et al
    Bridging the monitoring gap in resource-limited settings: A head-to-head evaluation of two Chinese HIV-1 RNA quantification assays and Roche TaqMan.
    PLoS One. 2026;21:e0354737.
    PubMed         Abstract available
    
    
31. MEEHAN SA, Hesseling AC, Kalk E, Hughes JA, et al
    Time to treatment initiation in pregnant women with tuberculosis in Cape Town, South Africa.
    PLoS One. 2026;21:e0344059.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

32. ZHOU P, Yuan M, Zhang Y, Limbo O, et al
    Directed evolution of a stem-helix-targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity.
    PLoS Pathog. 2026;22:e1014393.
    PubMed         Abstract available
    
    
33. SANDSTROM K, Hagedorn GN, Robinson SC, Katz JE, et al
    Long-term depletion of KIR3DL01+ NK cells by adeno-associated viral-vectored antibody delivery alters chronic SIV infection.
    PLoS Pathog. 2026;22:e1014508.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

34. YUAN Z, Board NL, Zhao M, Zu G, et al
    A TCR-mimic bispecific antibody reduces HIV-1 provirus and delays viral rebound in HLA-matched humanized mice.
    Proc Natl Acad Sci U S A. 2026;123:e2527880123.
    PubMed         Abstract available
    
    

    
    Science

35. COHEN J
    Weekly HIV pill moves closer but vaccine studies face new questions.
    Science. 2026;393:549-550.
    PubMed         Abstract available
    
    

    
    Vaccine

36. XU N, Wang L, Zhao C, Shen Y, et al
    Advances in clinical immunogenicity evaluation of influenza vaccines.
    Vaccine. 2026;89:128989.
    PubMed         Abstract available
    
    

    
    Virology

37. FRASER ME, Martin A, Mulvahill J, Dawson J, et al
    Suppression of HIV-1 replication in CEM-A cell cultures by trans-splicing group I introns targeting PAS/PBS sequences and conditionally expressing DeltaN-Bax.
    Virology. 2026;624:111044.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum